Demystifying NeoGenomics: Insights From 6 Analyst Reviews
Latest Ratings for NEO Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Needham Maintains Buy Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for NEO View the Latest Analyst Ratings read more